Effects of (+)-cyanidanol-3 on chronic liver injury. 1984

G Kovách, and F Salamon

Thirty patients of both sexes, suffering from alcoholic or diabetic liver injury, were studied in order to establish therapeutic effects of daily 3000 mg (+)-cyanidanol-3 administered for 3 weeks. In addition to subjective complaints, alterations in liver-specific enzyme-levels, changes in serumlipoids, the BSP half-time, activity of the microsomal enzyme-system and changes in the diabetic metabolism were studied. During the observation significant improvement of the disturbed enzyme-activities, decrease of the high lipoid level, reduction of the BSP half-time and the increasing activity of the microsomal enzyme-system could be proved. In case of diabetic patients a favourable change of the metabolic status could be established. Subjective complaints of patients subsided. In case of 17 patients the radionuclide HIDA method was applied too in order to study the dynamics of bile-transport. A moderately significant acceleration of the bile-transport could be observed. While continuing the treatment of 15 patients for 6 months, a control liver biopsy was carried out and in 10 cases it revealed favourable changes in the histological finding. During cyanidanol treatment gastrointestinal intolerance was observed in two patients, but only temporarily. Immune haemolysis did not occur.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008108 Liver Diseases, Alcoholic Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS. Alcoholic Liver Diseases,Alcoholic Liver Disease,Liver Disease, Alcoholic
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females

Related Publications

G Kovách, and F Salamon
March 1982, Lancet (London, England),
G Kovách, and F Salamon
January 1984, Therapia Hungarica (English edition),
G Kovách, and F Salamon
August 1986, Journal of the Royal Society of Medicine,
G Kovách, and F Salamon
March 1982, Lancet (London, England),
G Kovách, and F Salamon
April 1989, Anales de medicina interna (Madrid, Spain : 1984),
G Kovách, and F Salamon
April 1975, Biochemical pharmacology,
Copied contents to your clipboard!